PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
25-Oct-2020 Global Counterfeit Drug Detection Device Market (2020-27) Pheonix Research
23-Oct-2020 Partnering agreement in the field of gastrointestinal research - Biofortis/Prodigest Biofortis Merieux NutriSciences
22-Oct-2020 Dublin-based start-up launch Wirano – a global digital platform for organizing clinical trials Wirano
22-Oct-2020 Highlight Therapeutics & Pivotal advance into a Phase IIa trial to examine Gastro-Intestinal cancer therapy Highlight Therapeutics & Pivotal
21-Oct-2020 AARDEX Group partners with BIOCORP to extend digital solutions for precision medication adherence AARDEX Group
21-Oct-2020 Aurinia Pharmaceuticals selects MyMeds&Me’s Reportum QuickStart platform to streamline drug safety reporting MyMeds&Me
21-Oct-2020 Nanoform initiates GMP campaign for first-in-human trial of nanoformed drug by year end – ahead of schedule Nanoform
19-Oct-2020 New data presented at UEG Week Virtual 2020 show positive association between Remsima® SC pre-dose level with efficacy outcomes Celltrion Healthcare
19-Oct-2020 Janssen Receives CHMP Positive Opinion for Expanded Use of TREMFYA®▼ (guselkumab) in the Treatment of Active Psoriatic Arthritis (PsA) in the European Union (EU) Janssen
16-Oct-2020 Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody levels in preclinical studies Sanofi and Translate Bio
15-Oct-2020 New First-in-Class Phase 3 Data Demonstrate TREMFYA®▼ (guselkumab) Maintained Skin Clearance Rates Through Nearly 5 Years of Continuous Use in Adult Patients with Moderate to Severe Plaque Psoriasis Janssen Cilag ltd
14-Oct-2020 Evelo Biosciences Completes Enrollment in Phase 1b Clinical Trial Cohort Evaluating EDP1815 in Atopic Dermatitis Evelo Biosciences
14-Oct-2020 Formedix announces expansion to meet demands for clinical trial automation Formedix
14-Oct-2020 Vitalograph Launch Powerful New In2itive e-Diary for Global Clinical Trials Vitalograph
13-Oct-2020 PHASE 2B/3 TRIAL SHOWS EFFICACY OF FILGOTINIB FOR THE INDUCTION AND MAINTENANCE OF REMISSION IN MODERATELY AND SEVERELY ACTIVE ULCERATIVE COLITIS Ketchum
13-Oct-2020 Call for more BAME representation in COVID-19 trials will fail if long-held diversity challenges are not addressed Innovative Trials
13-Oct-2020 Kyowa Kirin Presents New Data on Response to Treatment in Cutaneous T-cell Lymphoma (CTCL) Patients Who Have Blood Involvement Kyowa
13-Oct-2020 Celltrion Initiates Post-exposure Prophylaxis Clinical Trial of an Anti-COVID-19 Monoclonal Antibody Treatment Candidate, CT-P59 Celltrion
13-Oct-2020 ProductLife Group Acquires Axpharma in Response to Accelerating Global Demand for Pharmacovigilance Support ProductLife Group
12-Oct-2020 STELARA® (ustekinumab) Five-Year Results Presented from Long-term Extension Study of Clinical Response and Remission in Patients with Moderate to Severe Crohn’s Disease Janssen Cilag ltd